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Abstract
During long-term cystic fibrosis lung infections, Pseudomonas aeruginosa undergoes genetic adaptation resulting in
progressively increased persistence and the generation of adaptive colony morphotypes. This includes small colony variants
(SCVs), auto-aggregative, hyper-adherent cells whose appearance correlates with poor lung function and persistence of
infection. The SCV morphotype is strongly linked to elevated levels of cyclic-di-GMP, a ubiquitous bacterial second
messenger that regulates the transition between motile and sessile, cooperative lifestyles. A genetic screen in PA01 for SCV-
related loci identified the yfiBNR operon, encoding a tripartite signaling module that regulates c-di-GMP levels in P.
aeruginosa. Subsequent analysis determined that YfiN is a membrane-integral diguanylate cyclase whose activity is tightly
controlled by YfiR, a small periplasmic protein, and the OmpA/Pal-like outer-membrane lipoprotein YfiB. Exopolysaccharide
synthesis was identified as the principal downstream target for YfiBNR, with increased production of Pel and Psl
exopolysaccharides responsible for many characteristic SCV behaviors. An yfi-dependent SCV was isolated from the sputum
of a CF patient. Consequently, the effect of the SCV morphology on persistence of infection was analyzed in vitro and in vivo
using the YfiN-mediated SCV as a representative strain. The SCV strain exhibited strong, exopolysaccharide-dependent
resistance to nematode scavenging and macrophage phagocytosis. Furthermore, the SCV strain effectively persisted over
many weeks in mouse infection models, despite exhibiting a marked fitness disadvantage in vitro. Exposure to sub-
inhibitory concentrations of antibiotics significantly decreased both the number of suppressors arising, and the relative
fitness disadvantage of the SCV mutant in vitro, suggesting that the SCV persistence phenotype may play a more important
role during antimicrobial chemotherapy. This study establishes YfiBNR as an important player in P. aeruginosa persistence,
and implicates a central role for c-di-GMP, and by extension the SCV phenotype in chronic infections.
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Introduction
Many bacterial pathogens are able to establish long-term
chronic infections within their respective hosts. The strategies and
mechanisms employed by pathogens to persist against attacks by
the host immune system and the action of antimicrobial substances
are still relatively poorly understood. An appreciation of these
processes is needed to develop strategies that help to avoid
complications with antibiotic resistance development and infection
relapses associated with prolonged colonization of host tissue. The
opportunistic pathogen Pseudomonas aeruginosa is responsible for
chronic infections in the airways of cystic fibrosis (CF) patients and
for much of the associated morbidity and mortality [1]. During
long-term lung colonization, P. aeruginosa undergoes phenotypic
and genetic adaptation resulting in the progressive loss of virulence
and the development of increased persistence [2]. As a
manifestation of this process, distinct adaptive colony morphotypes
of P. aeruginosa appear in CF sputum sample isolates. These include
mucoid colonies, which overproduce the exopolysaccharide
alginate [1], and small colony variants (SCVs), slow-growing
isolates characterized by several phenotypes including auto-
aggregation, attachment to surfaces [3] and enhanced exopoly-
saccharide production [3,4]. The appearance of P. aeruginosa SCVs
in CF sputum samples correlates with antibiotic resistance [5,6],
poor lung function, and persistence [7]. Likewise, Burkholderia
cepacia SCVs are associated with increased serum resistance and
fatal systemic infections post lung transplantation [8]. These
studies suggest that during the course of chronic lung infections,
SCVs are selected for due to a fitness advantage in this unique
environment, and that they might play an important role in the
pathogenesis of P. aeruginosa lung infections.
Following early indications [9,10], evidence has accumulated
that the SCV morphotype is strongly linked to the second
messenger cyclic-di-GMP (c-di-GMP) [11–13]. A recent study of
CF patients showed clear links between c-di-GMP-related systems,
and hence SCV, and chronic lung infection [2]. C-di-GMP is an
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ubiquitous bacterial second messenger that regulates the sessile-
motile transition in a wide range of species [14,15]. C-di-GMP is
produced from GTP by di-guanylate cyclases (DGC), and
degraded to pGpG by phosphodiesterases (PDE) [16]. These
enzymes contain the conserved GGDEF and EAL domains,
respectively [17–20]. GGDEF domains that harbor enzymatic
activity generally contain two conserved motifs; the catalytic active
(A) site, and the regulatory (I) site, required for non-competitive
product inhibition [21]. In general, elevated levels of c-di-GMP
are associated with a sessile, cooperative lifestyle. Phenotypes
expressed in this state include biofilm formation [22,23], enhanced
exopolysaccharide production [24,25], expression and production
of attachment factors [9,26], loss of various forms of motility
[27,28], and reduced virulence [29,30]. Conversely, low levels of
c-di-GMP promote a unicellular, free-swimming lifestyle.
The c-di-GMP regulatory system in P. aeruginosa is highly
complex, with 33 predicted GGDEF and 17 EAL domain-
containing proteins [15,29]. These proteins are thought to modulate
the intracellular c-di-GMP level and hence regulate the production
of numerous outputs. These include the exopolysaccharides Pel, Psl
and alginate [25,31,32], fimbrial adhesins [26], virulence and
cytotoxicity factors [29,33], pili [27,34,35] and flagella function [36].
Regulation of these output systems has been observed at the
transcriptional [32] and post-translational levels [25,31]. To date,
the biological roles and mechanisms of action of several P. aeruginosa
c-di-GMP signaling systems have been investigated. These include
the Wsp system [12,37,38], comprising a Che-like chemosensory
systemwith a DGC response-regulator output, WspR [12,37]. Over-
activation of WspR results in an SCV phenotype [9,12], displaying
strong attachment and increased expression of the pel and psl
exopolysaccharide operons [12,13]. Sad/RocARS [26,33] is a two-
component signaling system (RocS1) with two output proteins; a
transcriptional regulator (RocA1) and an EAL domain containing
protein (RocR). Sad/RocARS is required for biofilm maturation
[33] and regulates cup fimbriae expression [26]. This system is further
implicated in pathogenicity, with links to cyanide-mediated toxicity
[39] and type-III secretion [33]. The transition between reversible
and irreversible attachment in P. aeruginosa is regulated by the
putative hydrolase SadB [40], which promotes Pel exopolysacchar-
ide production and represses swarming motility [40,41]. These
processes are similarly co-regulated by the opposing enzymatic
activities of SadC, a membrane-bound DGC [36] and the PDE BifA
[42]. In addition, c-di-GMP has been associated with the response of
P. aeruginosa to antibiotic [10,43,44] and detergent-mediated [45]
stress, and with type IV pili production and control [27,34].
To investigate the role of c-di-GMP in the generation of the P.
aeruginosa SCV phenotype, we undertook a transposon mutagenesis
screen in strain PA01 for genes whose disruption produced
autoaggregative, Congo Red binding colonies. Three independent
transposon insertions were found in yfiR, the first gene of the
yfiBNR operon, which is highly conserved in many c-proteobac-
teria. Here we characterize the yfiBNR genes, and report that this
conserved system represents a tripartite signaling module that
regulates c-di-GMP levels in P. aeruginosa in response to as-yet
unknown environmental signals. YfiN acts as a membrane-integral
DGC whose activity is tightly controlled by YfiR, a small
periplasmic protein, and the OmpA/Pal-like outer-membrane
lipoprotein YfiB. The primary downstream target for the cyclic-di-
GMP produced by YfiBNR was identified as the Pel exopoly-
saccharide system, with transcription of pel genes being directly
proportional to the inferred output level of YfiN. Disruption of the
tight YfiN regulation via deletion of yfiR resulted in the generation
of an SCV morphology in PA01. Consequently, the DyfiR
genotype was used as a representative SCV in cell culture assays
and in a mouse model of persistent infection. Compared to PA01,
the DyfiR mutant exhibited strong, exopolysaccharide-dependent
resistance to macrophage phagocytosis. In addition, the SCV
phenotype was shown to effectively persist in a subcutaneous
catheter infection model. Together this establishes the YfiBNR
module as an important player in the persistence of P. aeruginosa
and implicates a role for c-di-GMP in chronic infections.
Materials and Methods
Strains and growth conditions
Strains and plasmids used in this study are listed in Table S1.
Primers are listed in Table S2. Unless otherwise stated, P. aeruginosa
PA01 and all E. coli strains were grown at 37uC in Luria Bertani
(LB) medium [46], solidified with 1.3% agar where appropriate.
For P. aeruginosa, gentamycin was used at 30 mg/ml (E. coli 20 mg/
ml), tetracycline at 50-100 mg/ml (E. coli 12.5 mg/ml), streptomy-
cin at 200 mg/ml (E. coli 50 mg/ml), and carbenicillin at 200 mg/
ml. For E. coli, kanamycin was used at 30 mg/ml and ampicillin at
100 mg/ml. Where required, chloramphenicol was added to
conjugation plates at 10 mg/ml. Congo Red dye was added to a
final concentration 0.04%. For inducible plasmids, vanillate was
added to a final concentration 1.0 mM, arabinose to 0.2% and
IPTG to 0.5 mM, as appropriate. J774 macrophages were
cultured in 150 ml RPMI medium (Sigma) supplemented with
2% Glutamine and 2% FCS, and incubated at 37uC, 5% CO2.
Molecular biology procedures
Cloning was carried out in accordance with standard molecular
biology techniques. pBBR5-yfiR was produced by ligation of the
yfiR PCR fragment (amplified with primers A and B, from PA01
genomic DNA), between the HindIII and BamHI sites of pBBR-
MCS5 [47]. pME-araC was constructed by ligation of the araC-
pBAD promoter fragment of pBAD18s [48] between the BamHI
and EcoRI sites of pME6032. pME-araC-yfiN was produced by
Author Summary
During long-term chronic infections of cystic fibrosis
patients, Pseudomonas aeruginosa adapts to the lung
environment, generating various different morphotypes
including small colony variants (SCVs), small, strongly
adherent colonies whose appearance correlates with
persistence of infection. The SCV morphology is strongly
associated with increased levels of the signaling molecule
cyclic di-GMP. In this study we investigated the connection
between cyclic di-GMP, SCV and persistence of infection.
Following a genetic screen for mutants that displayed SCV
morphologies, we identified and characterized the YfiBNR
system. YfiN is a membrane-bound cyclic di-GMP produc-
ing enzyme, whose activity is tightly controlled by YfiR and
YfiB. Cyclic di-GMP produced by YfiN boosts exopolysac-
charide synthesis, generating an SCV morphotype upon
YfiR-mediated release of YfiN repression. The resulting
YfiN-mediated SCV morphotype is highly resistant to
macrophage phagocytosis in vitro, suggesting a role for
the SCV phenotype in immune system evasion. Consistent
with this, YfiN de-repression increased the persistence of P.
aeruginosa in long-term infections in a mouse model. The
observation that the addition of antibiotics decreased the
number of suppressors, and the relative fitness disadvan-
tage of the YfiN-mediated SCV morphotype in liquid
culture, suggested that SCV-mediated persistence might
be favored during antimicrobial chemotherapy.
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ligation of the yfiN PCR fragment (amplified with primers C and
D, from PA01 genomic DNA), between the SacI and BglII sites of
pME-araC. Truncated and non-truncated yfiR-phoA fusion plas-
mids, and pME-yfiR-cherry were produced by ligation of SOE-
PCR/PCR fragments generated with primers F-J, BJ and BK
between the EcoRI and XhoI sites of pME-araC, and the EcoRI and
BglII sites of pME6032 respectively. The yfiBNR complementation
vectors were constructed by ligation of the relevant yfiBNR PCR
fragments (amplified with primers A, D, and E from PA01 and
DyfiR genomic DNA) between the HindIII and BamHI sites of
pUC18T-mini-Tn7T-Gm [49]. A and I site yfiN mutants were
constructed via SOE PCR [50], from template PCR fragments
amplified with primers A, D, E, and K-N. The plasmid pME6032-
yfiB was constructed by ligation of the yfiB PCR fragment
(amplified with primers E and O, from PA01 genomic DNA),
between the EcoRI and BamHI sites of pME6032 [51]. Plasmid
pBBR4-wspR was constructed by ligation of the EcoRI-HindIII
wspR fragment of plasmid pWspR12 [52] between the EcoRI and
HindIII sites of pBBR-MCS4 [47].
To produce a chromosomal M2-tagged copy of yfiR, the PCR
fragment amplified with primers A and E was ligated between the
HindIII and BamHI sites of pMR20 [53] and E. coli DY330 [54]
was transformed with the resulting plasmid. The PCR fragment
amplified with primers P and Q from plasmid pSUB11 [55] was
then used to produce an yfiR-M2 fusion in pMR20 by the method
described by Yu et al. [54]. The yfiR-M2 fusion was ligated into
the HindIII and BamHI sites of pUC18T-mini-Tn7T-Gm. The
PCR fragment amplified with primers R and S was used to
produce pAD6-V from plasmid pAD6 (A. Du¨rig, unpublished), by
the method described in [54].
The plasmids pET42b-yfiN and yfiB were constructed by
ligation of the relevant PCR fragments (amplified with primers
T-W, from PA01 genomic DNA), between the XhoI and NdeI sites
of pET42b (Novagen). Bacterial two-hybrid vectors were con-
structed by ligation of the relevant PCR fragments (amplified with
primers D, E, and X-AK from PA01 genomic DNA) between the
XbaI and BamHI sites of pUT18C and pKT25, and the HindIII
and BamHI sites of pUT18 [56].
Plasmid pME6032-luxCDABE was constructed by ligation of the
EcoRI-BamHI fragment of plasmid pSB417 [57] between the
EcoRI and BamHI sites of pME6032. Lux fusions with the cupA and
pel promoters were then constructed by ligation of EcoRI-excised
promoter fragments from plasmids pMPFCAL [58] and p-pelA-
lacZ [59] respectively into the EcoRI site of pME6032-luxCDABE.
Lux fusions with the cupB, cupC, psl and yfi promoters were
constructed by ligation of the relevant PCR fragments (amplified
with primers AL-AS, from PA01 genomic DNA), between the XhoI
and EcoRI sites of pME6032-luxCDABE.
Transduction with phage E79tv2
E79tv2 [60] transducing lysates were prepared as follows: 100 ml
of a donor overnight culture were mixed with 100 ml of wild type
phage (app. 107 to 105 PFU/ml), incubated for 10 min at 37uC
and mixed with 3 ml top-agar. The mixture was poured onto LB
plates and incubated at 37uC overnight. Top-agar with semi-
confluent plaques was then scraped from the plates and re-
suspended in 2 ml of TNM buffer (10 mM Tris HCl [pH 7.4], 150
mM NaCl, 10 mM MgSO4), vortexed and centrifuged at 20,000 g
for 10 min, the supernatant containing the transducing phage was
then transferred into a glass storage vial. For transduction, 500 ml
of an overnight culture of recipient strain was re-suspended in
500 ml TNM buffer, mixed with 500 ml of UV-attenuated
transducing lysate (56108 PFU/ml, 15 sec. UV Stratalinker
2400) and incubated at 37uC for 15 min. Non-adsorbed phage was
removed by washing twice in TNM buffer and samples were
plated onto selective media.
Transposon mutagenesis
The plasmid pALMAR3 was introduced into PA01 via
biparental mating with E. coli S17-1. Mariner transposon
insertions yielding an SCV morphology were selected on LB agar
containing tetracycline, chloramphenicol and Congo Red, and
restreaked onto fresh plates. The location of the transposon in
each SCV strain was determined by semi-random PCR [61], using
primers AT-AW.
Deletion of the yfiBNR genes
The strains PA01 DyfiNR and DyfiBNR were constructed via an
adaptation of the protocol described elsewhere [62]. Briefly,
deletion constructs were produced by SOE-PCR using primers
AX-BE, containing homologous flanking regions to the target
genes and FLP-excisable gentamycin cassettes. These constructs
were ligated into pEX18Ap between HindIII and KpnI. The
resulting vectors were then used to delete yfiNR/BNR as described
in [62]. PA01 DyfiR was deleted by two-step allelic exchange. A
deletion construct containing the flanking regions of yfiR was
produced by SOE-PCR using primers BF-BI and ligated between
HindIII and KpnI of pEX18Ap. The resulting vector was then
transformed into PA01. Following transformation, single cross-
overs were selected on carbenicillin and restreaked. Counter-
selection on 5% sucrose plates was used to force the resolution of
double crossovers. In all cases, deletion strains were confirmed by
colony PCR.
Attachment assays
Assays were adapted from [63]. 96 well plates containing 150 ml
LB medium/well were inoculated with single colonies using sterile
toothpicks, and incubated overnight at 37uC without shaking.
Plates were washed three times with distilled water. Remaining cell
material was then stained with 0.1% Crystal Violet solution (5%
methanol, 5% isopropanol) before further washing to remove
excess dye. Crystal Violet was re-dissolved in 20% acetic acid
solution and absorbance measured at 600 nm. Assays were
performed with 6 wells/strain and repeated independently at least
once in each case.
Motility assays
Swarm agar was based on TB and solidified with 0.5% agar.
After solidification, plates were dried overnight and then
inoculated on the surface with colonies re-suspended in LB. Plates
were incubated overnight at 37uC. Twitching motility was assayed
using TB plates containing 1% agar. Samples were stabbed
through the surface using toothpicks and plates incubated
overnight at 37uC. Twitching cells were visualized by staining
with 1% Crystal Violet following removal of the agar. Swimming
motility was assayed using TB plates containing 0.3% agar.
Colonies were stabbed into the agar using toothpicks and plates
incubated overnight at 37uC. Assays were repeated three times
independently.
Purification of N-terminal truncated YfiN and YfiB-His6
and production of antisera
200 ml of overnight cultures of BL21 pET42b-yfiN/yfiB were
used to inoculate 2L LB medium supplemented with kanamycin.
Cultures were grown for 2.5 hours at 37uC with shaking, His6-
yfiN/B expression was induced with 100 mM IPTG, and cultures
incubated for a further 2.5 hours at 30uC with shaking. Cells were
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harvested by centrifugation and lysed with 15 ml lysis buffer (250
mM NaCl, 10 mM Tris pH 8.0, 6.0 M urea). Insoluble cell debris
was harvested by centrifugation (30,000xg, 15 min, 4uC), and
truncated-YfiN-His6 and YfiB-His6 were purified from the
supernatant by nickel-NTA (BioRad) affinity chromatography.
Following binding to 0.5 ml nickel-NTA (4uC, 30 min, shaking)
proteins were eluted with a stepwise increase in imidazole
concentration, with both proteins eluting in 200 mM imidazole.
Native truncated-YfiN-His6 was purified as described, but without
6.0 M urea and with the addition of 10% glycerol to the lysis
buffer. A French Press was used to lyse the sample in place of urea.
Purified proteins were separated on preparative SDS gels, stained
with 4 M KCl, excised and sent to Laboratoire d’Hormonologie,
Marloie, Belgium for polyclonal antisera production. Protein
concentrations were assayed with a Protein Assay kit (BioRad).
Immunoblot analysis
Cell lysates from overnight cultures were separated on 15%
Tris-HCl gels and blotted onto polyvinylidene difluoride (PVDF)
membranes (Millipore). After overnight incubation in blocking
solution (1 x PBS pH 7.4, 0.01% Tween20, 5% milk powder),
proteins were detected with 1/5000 (a-M2, a-YfiB) or 1/500 (a-
YfiN) specific antiserum and 1/10,000 rabbit anti-mouse (a-M2)
or swine anti-rabbit (a-YfiB, a-YfiN) secondary antibody (Dako-
Cytomation). Bound antibodies were visualized with ECL
chemiluminescent detection reagent (Perkin-Elmer).
Diguanylate cyclase (DGC) activity assay
DGC activity was assayed as described previously [18,21].
Assays were run in 50 ml running buffer containing approximately
25 mg purified truncated-YfiN-His6 and started by the addition of
(final concentration) 100 mM GTP [18.5 kBq a33P-GTP]
(Amersham Biosciences). Samples were removed at regular
intervals and the reaction stopped with (final concentration) 250
mM EDTA. Purified DgcA [21] was included as a positive control.
Nucleotide extraction and analysis
Following protein purification, 100 ml of the truncated-YfiN-
His6 elution fraction was mixed with 200 ml of 0.5 M formic acid,
and nucleotides were extracted for 10 min at 4uC. Insoluble
components were then pelleted, and the supernatant directly
analyzed by chromatography after [21]. Nucleotides were
extracted and separated on a 125/4 Nucleosil 4000-1 polyethy-
leneimine column (Macherey-Nagel) using the SMART System
(Amersham Biosciences). The nucleotide peak corresponding to c-
di-GMP was verified by co-elution with a chemically synthesized
c-di-GMP standard.
Quantitation of cyclic-di-GMP by mass spectrometry
Log phase growing cultures of PA01 strains were cooled rapidly
in iced water and 5-10 ml of cells were concentrated by
centrifugation (5,300xg, 10 min, 4uC). Extracts were prepared
essentially as described in [64]. C-di-GMP levels were measured
by liquid chromatography-tandem mass spectrometry on an API
3000 triple quadrupole mass spectrometer (Applied Biosystems
Inc, Foster City, CA, USA) coupled with a Series 200 HPLC
System (Perkin Elmer Instruments, Norwalk, CT, USA). C-di-
GMP was detected via selected reaction monitoring (SRM) in
positive ionization mode. Liquid chromatography separation was
achieved on a reversed-phase column using an ammonium
acetate-methanol gradient (retention time for c-di-GMP: 8.6
min). Details of this method will be described elsewhere (Spangler
C. et al., manuscript in preparation). Following nucleotide
extraction, the pellet was dissolved in 800 ml 0.1 M NaOH by
heating for 15 min at 95uC. The protein content of each pellet was
then determined with a Protein Assay kit (BioRad). Measurements
were repeated at least in triplicate and values were expressed as
pmol c-di-GMP per mg protein.
In-vivo crosslinking assays
Overnight cultures of PA01 strains were washed once and re-
suspended in 1 volume PBS. An aliquot was removed, and
crosslinking started by the addition of 1% formaldehyde. Aliquots
were removed after 20 minutes crosslinking at room temperature,
and washed once to remove formaldehyde. Benzon nuclease was
added to digest DNA (5 U, 30 min, RT) and samples were boiled
(20 min, 95uC) where required. Samples were subsequently
analyzed by Western blotting.
Subcellular localization of proteins
For the fractionation of soluble and membrane proteins, an
overnight culture of PA01::yfiR-M2 was re-suspended in 0.2
volumes lysis buffer (20 mM Tris pH 8.0, 250 mM NaCl, protease
inhibitor cocktail (Roche)). Cells were lysed by French Press and
centrifuged to remove cell debris (10,000 g, 1 hour, 4uC). The
soluble and insoluble cell fractions were then separated by
ultracentrifugation (100,000 g, 3 hours, 4uC). Samples were
subsequently analyzed by immunoblotting. For the fractionation of
periplasmic proteins, overnight cultures were resuspended in 0.125
volumes osmotic shock buffer (50 mM Tris pH 8.0, 20% sucrose, 2
mM EDTA) and incubated at room temperature for 30 to 60 min,
depending on the strain. Samples were centrifuged (15,000 g, 10
minutes, 4uC) and the supernatant and pellet collected. The pellet
fraction was washed twice and resuspended in PBS. The
supernatant (periplasmic fraction) was either subjected to alkaline
phosphatase assays directly, or proteins were precipitated with 5%
TCA, washed twice with di-ethyl ether and resuspended in PBS
before immunoblot analysis.
Alkaline phosphatase assay
Alkaline phosphatase activity was assayed for YfiR-PhoA
protein fusions by measuring the rate of p-nitrophenyl-phosphate
hydrolysis according to the method described in [65]. Assays were
carried out in triplicate for each protein fusion and the experiment
was repeated independently.
Bacterial two-hybrid
Bacterial two-hybrid assays were carried out after [66]. E. coli
MM337 cells were freshly transformed with constructs contain-
ing potential interaction partners. Transformants were then
streaked onto MacConkey base and M9 plates, supplemented
with 0.5% maltose, kanamycin and ampicillin. Plates were
incubated for two days at 30uC and positive interactions
distinguished by red coloration on MacConkey and growth on
M9 plates.
Luminescence assay for promoter activity
Strains containing pME6032-promoter-lux fusion constructs were
streaked onto LB plates containing tetracycline, incubated
overnight and the resulting colonies used to inoculate LB cultures.
These cultures were grown for 6 hours at 37uC and then two
150 ml aliquots were transferred to a black, clear-bottomed 96-well
plate (Costar). Luminescence and OD600 were recorded for each
sample using a Synergy 2 plate reader (Biotek). Samples were
repeated in triplicate for each promoter fusion and the assay
repeated independently at least twice.
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Scanning electron microscopy
Cells were grown overnight at 37uC, in 2 ml LB in 24-well
plates and in the presence of a hanging sterile glass slide. After
growth, the glass slides were removed, rinsed gently with 1x PBS
and fixed in 2.5% glutaraldehyde in 1x PBS for 2 h at RT.
Glutaraldehyde was washed out with 1x PBS and subsequently
with water, and the sample dehydrated with an acetone step
gradient (30%, 50%, 70%, 90%, 100%; 10 min each). Samples
were critical point-dried and sputter-coated with a 3–5 nm
platinum layer. Micrographs were recorded on a Hitachi S-4800
field emission scanning electron microscope. Acceleration voltage
was generally between 1.5 and 5 kV.
Nematode absorption assays
100 mL drops of PA01 overnight cultures were dried onto M9
plates with 0.4% glucose, and the plates incubated overnight at 37
uC. Approximately 20 adult Caenorhabditis elegans were added to
each plate, and plates were incubated at room temperature for 72
hours. For GFP labeling experiments, PA01 strains containing
pAD6-V were used and incubated with C. elegans for 3 hours before
imaging.
Macrophage phagocytosis and NF-kB activation assays
J774 macrophages were incubated overnight in a black, clear-
bottomed 96-well plate, at a concentration of 26104 cells/well.
Lysotracker red dye (Invitrogen) was added to each well 30 minutes
prior to infection. PA01 strains containing pAD6-V were grown in
LB for 4 hours at 37uC and then used to infect the mature
macrophages (final MOI 5). Samples were vortexed thoroughly at
every stage of the preparation process to minimize the proportion
of cell aggregates in the inoculum. After 2 hours incubation at
37uC, 5% CO2, macrophages were fixed by the addition of 4%
PFA solution. Wells were washed with PBS and stained with
Hoechst 33342, then subjected to analysis with an ImageXpressMI-
CRO microscope running MetaXpress 2.0 (Molecular Devices). For
the NF-kB activation assay, the Lysotracker stain was omitted, and
the macrophages permeabilised with Triton-X100 and stained with
an anti-NF-kB p65 antibody (Santa Cruz Biotechnology) following
infection. The Translocation enhanced analysis module of
MetaXpress was used to calculate the ratio of cytosolic to nuclear
p65 intensity at the single cell level. Six wells were inoculated per
strain and each assay was repeated independently.
Siderophore and pyocyanin production
Siderophore and pyocyanin levels were measured in the
supernatants of overnight cultures grown in M9 plus 0.4% glucose
and 0.2% casamino acids (Pyoverdin, Pyochelin) and LB
(Pyocyanin) using the methods described in [67].
LDH release assay for cytotoxicity
J774 macrophages were inoculated in a 24 well plate, at a
concentration of 16105 cells/well and incubated overnight.
Overnight cultures of PA01 strains were inoculated into LB,
grown for 6 hours at 37uC and used to infect the mature
macrophages (final MOI 10). After 3 hours incubation (37uC, 5%
CO2), LDH release was measured with a CytoTox96 kit
(Promega) according to the manufacturer’s instructions. Values
were calculated as a percentage of the positive control (+ 0.5%
TritonX100), and each sample was repeated in triplicate.
Infection models
C57BL/6 mice (10–14 weeks old) were obtained from RCC
(Fu¨llinsdorf, BL, Switzerland) and kept in the animal facility of the
Department of Biomedicine, University Hospitals Basel; animal
experimentation guidelines were followed in accordance with the
regulations of Swiss veterinary law. Methods employed were
approved by the review board of the Kantonales Veterina¨ramt
Basel-Stadt (permit no. 1957). Mice were infected as described
elsewhere [68], with minor modifications. Briefly, mice were
anesthetized with 20 mg/kg Ketalar (Pfizer) and 4 mg/kg xylazinum
(Graeub). A 3–4 mm incision was made 1–1.5 cm lateral to the spine,
and a catheter segment (1 cm Vialon IV catheters, diameter of 2.1
mm; Becton Dickinson), was inserted subcutaneously. Next, 25 ml of
pyrogen-free saline containing 10,000 cfu of PA01-GmR (wt), DyfiR
or DyfiBNR bacteria grown to exponential phase in LB medium was
injected into the beds of uncoated catheters, and the incision was
closed with wound clips. Four and eight weeks after infection, mice
were sacrificed and the catheter and surrounding tissue were
aseptically removed and separated. Catheters were vortexed in
saline, 0.15% EDTA, and 0.1% Triton X-100 and sonicated for 3
min at 130 W. Tissue samples were homogenized, dilutions from
both preparations were plated onto LB agar plates, and colony-
forming units were counted following overnight incubation at 37uC.
For competition experiments, wt and DyfiR or DyfiBNR bacteria were
injected at a 1:1 ratio. Differences in colony morphology were used to
distinguish between wild type and DyfiRmutant colonies. Statistically
significant differences were determined using theMann-Whitney test.
Antibiotic survival assay
Glass tubes containing 4 ml LB and tobramycin (0–2.0 mg/ml)
were inoculated with 10,000 cfu of PA01-GmR (wt) or DyfiR. After
18 hours incubation at 37uC with shaking, dilutions were plated
onto LB agar plates containing Congo Red. Colony-forming units
were counted following overnight incubation at 37uC. Statistically
significant differences between samples were determined using the
Mann-Whitney test. Five replicates were run for each sample.
Results
The yfiBNR operon is an SCV-related locus in
Pseudomonas aeruginosa
To begin our analysis of the SCV phenotype, we sought to
identify those loci in P. aeruginosa PA01 whose disruption led to a
characteristic SCV morphology and behavior. A comprehensive
transposon mutagenesis screen was conducted, selecting for
mutants that stably maintained an SCV phenotype on LB Congo
Red agar plates (i.e. that could be maintained by serial re-streaking
without losing the SCV phenotype). Three independent transpo-
son insertions were mapped to yfiR (PA1121), the first gene of the
predicted three-gene operon yfiBNR (Figure 1A). In silico analysis
predicted that yfiN encodes a 47.5 kDa protein with two
transmembrane helices flanking a periplasmic PAS-like domain,
a HAMP domain and a GGDEF domain with a conserved
GGDEF active-site motif. YfiB was predicted to be an 18.4 kDa
outer-membrane lipoprotein with a conserved OmpA peptidogly-
can binding domain [69], while yfiR encodes a 20.7 kDa protein
with a probable signal peptide but no predicted tertiary structure
[70–72](Figure 1B).
Given the established link between c-di-GMP production and
SCV and the fact that YfiN has been suggested to function as a
DGC [29], we hypothesized that the SCV phenotype of the yfiR
transposon insertions was caused by up-regulation of YfiN activity.
This would occur either via the release of repression by YfiR or as
a consequence of polar effects from the Tn insertions on the yfiN
and/or yfiB genes. The yfiR::Tn phenotype was successfully
complemented in trans with a plasmid-borne wild type copy of
yfiR (data not shown), and an in-frame deletion of yfiR yielded an
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SCV phenotype indistinguishable from that of the transposon
mutants (Figure 1C). The yfiR transposon mutants (data not
shown) as well as the DyfiR mutant (Figure 1D) showed an almost
10-fold increased propensity for surface attachment. Over-
expression of PA5295, a PDE from P. aeruginosa [73], but not of
an active site mutant (PA5295AAL), reduced DyfiR attachment to
wild type levels and abolished the SCV phenotype (Figure 1D).
Swimming, swarming, and twitching motility were severely
impaired in DyfiR compared to wild type PA01 (Figure S1).
Similarly to the SCV phenotype, these motility defects were fully
complemented by expression of yfiR in cis or in trans (Figure S1D).
To determine the nature of the YfiBNR system output, a His6-
tagged version of YfiN lacking the 182 residues corresponding to
the transmembrane region (truncated-YfiN-His6) was purified and
tested for DGC activity. DGC activity was previously suggested for
YfiN of P. aeruginosa strain PA14 based on HPLC analysis of over-
expression strains [29]. In accordance with these findings,
truncated-YfiN-His6 generated c-di-GMP from GTP, confirming
that YfiN functions as a DGC (Figure 2A). HPLC analysis of the
effluent co-eluting with the purified truncated-YfiN-His6 fraction
indicated the presence of large amounts of c-di-GMP (Figure 2B),
consistent with the idea that the YfiN GGDEF domain contains a
conserved high-affinity binding site utilized for allosteric product
inhibition (I-site) [21]. These results indicated that the DyfiR SCV
phenotype is a consequence of derepressed YfiN DGC activity. To
confirm this, we determined the cellular concentration of c-di-
GMP in wild type and mutant strains. In growing cells of PA01
wild type and a strain lacking YfiN (DyfiBNR, see below) the
concentration of c-di-GMP was 3.5460.67 pmol/mg protein and
2.3960.33 pmol/mg, respectively. In contrast, a strain lacking
YfiR (289.30636.53 pmol/mg) or over-expressing yfiN from a
plasmid (1835.706235.93 pmol/mg) showed a marked increase of
c-di-GMP. Together, these data strongly suggest that YfiR
functions to negatively regulate YfiN, and that the DyfiR SCV
phenotype results from de-repression of YfiN DGC activity,
leading to increased levels of c-di-GMP.
YfiB and YfiR inversely control YfiN activity
In order to understand the regulatory interplay of the YfiB,
YfiN and YfiR proteins, a series of epistasis experiments were
Figure 1. The YfiBNR system of Pseudomonas aeruginosa. A) Organization of the yfiBNR operon. Transposon insertions in yfiR inducing the SCV
phenotype are marked with grey triangles. B) Domain organization of the Yfi proteins. S.S. (YfiR) denotes an export signal sequence, vertical grey bars
(YfiN) represent transmembrane helices, and OMP (YfiB) denotes the OmpA/Pal-like protein fold. The HAMP and GGDEF domains of YfiN are labeled.
C) Colony morphology of the yfiR::Tn mutants grown on LB Congo-red agar. The morphology of the non-polar yfiR deletion is indistinguishable from
the yfiR::Tn strains. D) Over-expression of the phosphodiesterase PA5295 abolishes surface attachment and SCV morphology of the DyfiR mutant.
PA5295-AAL denotes an active site mutant of PA5295. Attachment levels are expressed relative to PA01. The graph shows a representative of two
independent experiments.
doi:10.1371/journal.ppat.1000804.g001
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performed. In addition to the DyfiR mutant, DyfiNR and DyfiBNR
deletion strains were constructed. As expected, both strains
displayed wild type colony morphology (data not shown) and
reduced attachment (Figure 3A), indicating that YfiN contributes
to surface attachment of PA01 wild type under the conditions
tested, and that YfiN is the effector of the SCV phenotype in the
DyfiR mutant. A series of yfiBNR alleles were then constructed and
inserted into the att-Tn7 locus of DyfiBNR (a strain that harbors a
deletion of the entire yfi operon). In this way, the effects of all
combinations of yfiB, yfiN, and yfiR mutations could be tested.
Replacement of the full yfiBNR operon at att-Tn7 yielded a
phenotype indistinguishable from wild type PA01 (Figure 3A, B).
Likewise, complementation with yfiBNDR produced an SCV
phenotype with an attachment level comparable to the DyfiR
mutant (Figure 3A, B). These results demonstrated that the Tn7-
complementation strains can be used to model the effects of yfiBNR
disruptions in vivo.
Comparison of the morphology and attachment of the Tn7-
based complementation strains led to several observations
(Figure 3A, B). Firstly, deletion of yfiN, or expression of an yfiN
active site (A-site) mutant (yfiND330A) produced a wild type colony
morphology and an attachment level around 60% of wild type,
independent of the presence or absence of yfiR or yfiB. Secondly,
deletion of yfiR produced the characteristic SCV morphology in
any strain with a wild type version of yfiN. Deletion of yfiB did
not affect attachment or colony morphology, and a DyfiRB
double mutant behaved similarly to a DyfiR single mutant,
suggesting that yfiR is epistatic over yfiB and that YfiB may
function upstream of YfiR. Over-expression of yfiB in trans led to
a two-fold increase in DyfiBNR Tn7::yfiBNR attachment
(Figure 3C, ‘FL’). This effect was dependent upon the presence
of YfiR, and on a functional copy of YfiN; no attachment
increase was seen upon yfiB expression in either strain DyfiBNR
Tn7::yfiBNDR or in strain DyfiBNR Tn7::yfiBND330AR (Figure 3C,
‘DyfiR’ and ‘FL A-site’). These data support the hypothesis that
YfiB functions upstream of YfiR. Thirdly, the stoichiometry of
YfiR and YfiN appears to be critical for the tight control of the
Yfi system (Figure 3D, E). Basal level expression of yfiN from the
plasmid p-ara-yfiN lead to increased levels of YfiN relative to
YfiR, and to a SCV phenotype in PA01 wild type. This SCV
morphology was suppressed by the introduction of a plasmid
expressing yfiR (p-yfiR). When yfiN expression in this strain was
induced with arabinose, levels of YfiN once again dominated,
leading to an SCV phenotype (Figure 3D). Similarly, adding a
second copy of yfiN to the PA01 wild type chromosome (inserted
into the att-Tn7 locus) produced an SCV phenotype with a lower
level of attachment than DyfiR, accounting for the chromosomal
copy of yfiR present, while the wild type phenotype was
maintained when additional copies of both yfiN and yfiR were
added (Figure 3E). Finally, an yfiN I-site mutation (yfiNR319A) only
partially complemented wild type yfiN. Because immunoblot
analysis showed reduced levels of the YfiN I-site mutant as
compared to wild type (Figure 3A), this may be due to reduced
stability of the mutant protein. Despite the reduced effectiveness
of yfiNR319A, we were unable to introduce this allele into a strain
that lacked yfiR, suggesting that loss of both YfiR-mediated
inhibition of YfiN activity and YfiN feedback control produces a
highly toxic situation, similar to that observed for feedback
negative mutants of C. crescentus DgcA [21]. This in turn implies
that YfiN, in addition to its regulation by YfiR, is subject to tight
feedback control via I-site binding of c-di-GMP. Together, these
data strongly indicate that the diguanylate cyclase YfiN is subject
to tight negative control by YfiR and that YfiB, directly or
indirectly, counteracts this inhibitory effect.
YfiR is a periplasmic protein
Epistasis experiments indicated that YfiR plays an important
role in regulating YfiN activity, possibly by relaying information
from YfiB in the outer membrane to YfiN in the cytoplasmic
membrane. Such a mechanism would predict that YfiR is located
in the periplasm. To test this and due to the absence of an effective
YfiR antibody, yfiR triple-M2 tagged (yfiR-M2) reporter strains
were constructed. Insertion of the yfiR-M2 allele into the att-Tn7
locus of a DyfiR mutant restored the wild type phenotype,
indicating that YfiR-M2 is fully functional (data not shown). The
subcellular location of YfiR-M2 was subsequently investigated
upon fractionation of cell extracts by ultracentrifugation followed
by immunoblot analysis (Figure 4A). Because YfiB is predicted to
localize to the outer membrane [70,72], it was included as a
control. As expected, YfiB almost exclusively localized to the
insoluble, membrane-associated fraction. YfiR-M2 was found
exclusively in the soluble fraction (Figure 4A). Next, a strain
expressing both yfiR-M2 and gfp (PA01 yfiR-M2 pAD6-V) was
subjected to periplasmic extraction by osmotic shock, and the
fractions were analyzed by immunoblotting. As expected for a
cytosolic protein, GFP was detected in the whole-cell and
spheroplast fractions only, confirming that cell fractionation did
not result in spheroplast lysis. In contrast, YfiR-M2 was found
exclusively in the periplasmic fraction (Figure 4B).
To provide further evidence for the periplasmic location of
YfiR, an yfiR-phoA fusion was analyzed. This construct was able to
complement the SCV morphology of a DyfiR mutant (Figure S2B),
indicating that the YfiR section of the fusion protein was fully
Figure 2. YfiN is a diguanylate cyclase. A) A truncated YfiN lacking
the transmembrane and periplasmic parts has DGC activity in vitro. C-di-
GMP production was observed on TLC plates over time against a
positive control (DgcA). The c-di-GMP peak is marked with an arrow. B)
YfiN binding of c-di-GMP. Elution and wash fractions from YfiN
purification were run on an HPLC column and the absorbance at 254
nm plotted. The elution fraction contains a large c-di-GMP peak,
presumably bound by YfiN, and not seen in the wash fraction.
doi:10.1371/journal.ppat.1000804.g002
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Figure 3. Epistasis and regulation of the YfiBNR system. A) Attachment of yfiBNR mutant strains. The bars marked ‘DyfiBNR Tn7::’ depict Tn7
complementation strains containing variants of the yfiBNR operon inserted into the att-Tn7 site of DyfiBNR. For these, ‘FL’ refers to the full-length
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functional. PA01 wild type containing the full length YfiR-PhoA
fusion displayed strong phosphatase activity, with a large
proportion of this activity localized to the periplasmic fraction
(Figure S2A). In contrast, an yfiR-phoA allele lacking the
presumable YfiR export signal was unable to complement the
DyfiR SCV morphology and showed little or no phosphatase
yfiBNR operon, ‘A-site’ refers to the yfiN active-site mutant D330A, and ‘I site’ to the yfiN feedback-inhibition-site mutant R319A. Strains without an
active copy of yfiN (light grey) display reduced attachment compared to those containing active copies of both yfiN and yfiR (white). Strains missing
yfiR but containing yfiN (dark grey) showed a large increase in attachment. Immunoblots show the levels of YfiB and YfiN present in each strain. B)
Colony morphology of selected Tn7 complementation strains. Deletion of yfiR induces a small colony variant phenotype. Deletion of yfiB has no effect
on morphology, either alone or combined with an yfiR deletion. C) Over-expression of yfiB in trans induces SCV colony morphology and stimulates
PA01 attachment in an yfiN- and yfiR-dependent manner. yfiB expression is induced in Tn7 complementation strains, which are labeled as in 3A. The
colony morphologies of these strains with and without induction of yfiB expression are shown on the right. D) YfiR and YfiN expressed in trans act
antagonistically on PA01 colony morphology and attachment. The X-axis of the graph shows the plasmids present in each case. Colony morphologies
with and without induction of yfiN expression are shown on the right. E) The full-length yfiBNR operon (FL) and DyfiR Tn7 complementation
constructs were inserted into the att-Tn7 site of PA01. Attachment levels for all assays are shown relative to PA01.
doi:10.1371/journal.ppat.1000804.g003
Figure 4. The YfiBNR complex. A) Membrane localization of YfiB and YfiR. Membrane fractionation was carried out with PA01 yfiR-M2. The
separate fractions are labeled as follows: C = whole cell sample, L = cell lysate, S = soluble fraction, M = membrane fraction. YfiB localizes to the
membrane fraction, YfiR-M2 to the soluble fraction. B) Periplasmic localization of YfiR. Periplasmic fractionation was carried out with PA01 yfiR-M2
pAD6V, and YfiR-M2 and GFP were detected by immunoblot analysis. GFP localizes to the spheroplast (cytosolic/membrane) fraction, while YfiR-M2
localizes to the periplasmic fraction. C) In-vivo crosslinking of YfiR-M2. Whole cell samples of PA01 yfiR-M2, DyfiN yfiR-M2, and DyfiBN yfiR-M2 mutant
strains were crosslinked by addition of formaldehyde and YfiR-M2 detected by immunoblot analysis. 0 = sample before crosslinking; 20 = sample
taken 20 min after formaldehyde addition; 20* = 20 min sample, boiled to break crosslinks. Black arrows indicate major bands corresponding in size to
an YfiR-M2 monomer (20 kDa) and an YfiR-M2 oligomer (40 kDa), respectively. D) Bacterial two-hybrid analysis of YfiN and YfiR interactions. Positive
interactions produce a red color on MacConkey indicator plates. Clockwise from top left, the cartoons denote YfiN-YfiN, YfiR-YfiR and HAMP domain-
YfiN interactions. E) A model for YfiBNR function. YfiN is a membrane-localized DGC and is subject to product inhibition and control by YfiR. YfiB
activates YfiN, possibly by releasing YfiR-mediated repression. OM and IM refer to the outer and inner membranes, respectively and PG refers to the
peptidoglycan layer.
doi:10.1371/journal.ppat.1000804.g004
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activity (Figure S2A, B). Finally, an yfiR-Mcherry fusion was
constructed and shown to fully complement the DyfiR SCV
phenotype (data not shown). When protein localization was
visualized by fluorescence microscopy in PA01, the red fluorescent
YfiR fusion protein was found exclusively in the cell perimeter
(Figure S2C). Together, these data strongly suggest that YfiR is
indeed located primarily in the periplasm.
The genetic interaction between YfiB and YfiR together with
their presumable location in the outer membrane and periplasm,
respectively, prompted us to gather more direct evidence for a link
between YfiB and YfiR function. In vivo cross-linking experiments
were performed, in which YfiR-M2 containing strains were treated
with formaldehyde followed by immunoblot analysis of the cross-
linked lysates (Figure 4C). In a wild type background, formalde-
hyde treated samples showed a clear shift of YfiR-M2 from the
monomeric state (19.8 kDa, without the signal sequence) to a
multimer of approximately 40–42 kDa. This multimer was absent
in a strain that lacked both YfiB and YfiN (DyfiBN yfiR-M2), but
was present in a strain that only lacked YfiN (DyfiN yfiR-M2)
(Figure 4C), indicating that YfiB, but not YfiN, is required for YfiR
oligomerisation. Immunoblotting with YfiB antiserum failed to
detect a band of similar size (data not shown). Whilst the nature of
the YfiR multimer is currently unknown, its size is consistent with
an YfiR-YfiR homodimer.
Bacterial-two hybrid analysis failed to provide evidence for
direct interaction between YfiR and the isolated periplasmic or
cytoplasmic domains of YfiN, and between YfiB and any other
protein variant (Table S3). Given the different subcellular
localization of these proteins some of these negative results might
reflect limitations in the experimental procedure. A truncated
variant of YfiR missing the predicted signal peptide (residues 1-34)
[70] interacted strongly with itself (Figure 4D), consistent with the
results obtained from cross-linking experiments (see above). Also,
while no interaction was observed with the full-length YfiN (data
not shown), a truncated version of YfiN missing its transmembrane
region (residues 1-182) formed strong interactions with itself
(Figure 4D), arguing that, like other DGCs [74-76], YfiN functions
as a dimer and that the membrane spanning part of YfiN
negatively controls YfiN dimerisation. The isolated HAMP
domain, but not the isolated GGDEF domain of YfiN also
interacted with the truncated YfiN variant, suggesting that the
HAMP domain is involved in YfiN multimerization (Figure 4D).
Together, these data suggest that YfiB and YfiR are localized
outside of the cell and together control YfiN activity.
The YfiBNR system controls the Pel and Psl
exopolysaccharide systems
Elevated levels of c-di-GMP have been linked to a number of
biofilm-promoting systems including Pel and Psl exopolysacchar-
ides [12] and the Cup fimbrial adhesins [9,11,26]. To identify
potential downstream targets of YfiN that contribute to the SCV
behavior, the DyfiR deletion allele was combined with disruptions
in several of these c-di-GMP output systems. Disruption of pel
(pelG::Tn) or psl (DpslAB) strongly attenuated the SCV phenotype
of a DyfiR mutant, resulting in strains with altered colony
morphologies and Congo Red binding on LB-agar plates
(Figure 5A), as well as significantly reduced attachment
(Figure 5B). Importantly, a pelG::Tn DpslAB DyfiR triple mutant
exhibited a smooth colony morphology, a marked loss of Congo
Red binding and complete abolishment of surface attachment. In
contrast, mutational disruption of the CupA (cupA4::Tn), CupB
(cupB4::Tn), or CupC (cupC2::Tn) fimbrial adhesins showed no
discernable effects on the DyfiR SCV phenotype (Figure 5A, B).
Over-expression of wspR19, which encodes a constitutively active
DGC [52] produced high levels of attachment, comparable to the
DyfiR mutant. However, in this case up-regulation of Pel alone
seems to be responsible for increased attachment, as disruption of
psl produced little effect (Figure 5B). Disruption of pel and psl in the
DyfiR background failed to restore swimming and twitching
motility and only partially restored swarming motility (Figure
S1). This suggested that the impairment of cellular motility in the
DyfiR mutant is not an indirect consequence of Pel and Psl
Figure 5. Downstream components of the YfiBNR system. A)
Colony morphologies of mutants lacking potential downstream targets
of the YfiBNR system grown on LB Congo Red agar. 1 = PA01, 2 = DyfiR,
3 = DyfiR pelG::Tn, 4 = DyfiR DpslAB, 5 = DyfiR DpslAB pelG::Tn, 6 = DyfiR
cupA4::Tn, 7 = DyfiR cupB4::Tn, 8 = DyfiR cupC2::Tn. B) Attachment of
mutants lacking potential downstream targets of the YfiBNR system,
relative to PA01. C) YfiBNR effects on downstream gene transcription.
Values are expressed as the percentage of luminescence reporter gene
expression in DyfiR or DyfiBNR, as compared to PA01 wild type. The
control strain contains pME6032-luxCDABE. Transcription of pel is
massively up-regulated in DyfiR, and down regulated in DyfiBNR.
doi:10.1371/journal.ppat.1000804.g005
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exopolysaccharide overproduction and that additional, motility-
related systems are affected.
To investigate the relationship between YfiBNR and its
downstream targets in more detail, gene transcription in different
Dyfi-backgrounds was probed using lux-promoter fusion constructs
(Figure 5C). Compared to PA01, deletion of the entire yfiBNR
operon led to a 40% drop in pel transcription level, which likely
contributes to the reduced attachment level seen in DyfiBNR
(Figure 3A). In contrast, in a DyfiR background, pel transcription
was massively induced compared to PA01. Transcription of the psl
and cupB operons was subject to a modest two-fold increase in
DyfiR over wild type levels. Interestingly, cupA transcription was
strongly inhibited in this strain under the conditions tested.
Electron micrographs of PA01 and DyfiR strains (Figure S3)
showed cells embedded in a dense matrix of thin fibres. This
matrix was markedly thicker for the DyfiR mutant, and the cells in
this case appeared to form a more structured biofilm. In PA01,
disruption of both pel and psl greatly reduced biofilm formation
(Figure S3). In the DyfiR background, disruption of pel did not
abolish biofilm formation, but the biofilm that was formed
displayed few extracellular fibres, suggesting that Pel is a
component of the extracellular matrix. DyfiR DpslAB produced
both a biofilm and extracellular fibres, but the latter in this case
were irregularly distributed and had a ‘ragged’ appearance, in
contrast to the thick, even matrix seen with the parental DyfiR
strain (Figure S3). Little or no biofilm formation was observed
when both pel and psl were disrupted in either yfiR background
(data not shown). Together, these data indicate that de-repression
of YfiN leads to the activation of the Pel and Psl exopolysaccharide
systems, and that most of the morphological and behavioral
characteristics of the DyfiR SCV are mediated by the up-regulation
of Pel and Psl.
YfiN-dependent up-regulation of Pel and Psl
exopolysaccharide systems confers resistance against
phagocytosis
The clinical SCV phenotype is associated with persistence in CF
lung infections [7]. In addition, SCV is a highly aggregative
phenotype associated with over-production of exopolysaccharide
in both clinical [4] and lab strains [77]. To determine whether
yfiBNR mutations give rise to SCVs in CF lung infections, ten SCV
strains isolated from the sputum of CF patients were transformed
with pMR20-yfiR-M2. The SCV phenotype of one of these strains,
ClinSCV-110, was abolished by yfiR-M2 expression, similarly to
the DyfiR SCV mutant (Figure S4). This strongly suggested that the
SCV phenotype in this case arose as the consequence of a
mutation in the yfi operon, and validates the use of the DyfiR
mutant as a model SCV for subsequent in vivo analyses.
To assay the persistence behavior of the DyfiR mutant and to
test the hypothesis that persistence was related to the exopoly-
saccharide components of the biofilm, we analyzed the interaction
of the DyfiR mutant with both murine immune cells and external
predators. Caenorhabditis elegans, incubated for 72 hours on minimal
agar plates onto which drops of PA01 had been spotted grew to
maturity with no apparent adverse effects (Figure 6A, panel 1). In
contrast, nematodes incubated with DyfiR were starved, with many
individuals in the dauer larva stage, a stage reflecting low food
resources (Figure 6A, panel 2). When incubated for three hours on
GFP-labeled cells, the gut of nematodes fed with PA01 was filled
with green bacteria (Figure 6A, panel 1 inset), while nematodes fed
on DyfiR showed almost no bacteria in the gut (Figure 6A, panel 2
inset). Disruption of either the pel or psl operon alone was
insufficient to overcome the resistance of the DyfiR mutant to
effective nematode scavenging (Figure 6A, panels 3-4). However, a
DyfiR pelG::Tn DpslAB triple mutant was consumed readily;
nematodes incubated with this strain grew to maturity in the
same way as with wild type PA01 (Figure 6A, panel 5). These
Figure 6. YfiN-mediated SCVs resist nematode predation and
phagocytosis. A) SCV resistance to nematode predation. Panel 1
shows C. elegans incubated with PA01 as a food source for 72 hours.
Panels 2 to 5 show the corresponding experiments with DyfiR (2), DyfiR
pelG::Tn (3), DyfiR DpslAB (4) and DyfiR pelG::Tn DpslAB (5), respectively.
Eggs and mature adults were seen with PA01 (1) and the double
exopolysaccharide mutant (5) only. Worms and larvae are indicated
with black arrows. Insets to panels 1 and 2 show nematodes incubated
for three hours with GFP-labeled PA01 or DyfiR, respectively. B)
Macrophage absorption assay. Values shown are the fraction of J774
macrophages whose lysosomes co-localize with at least one bacterium.
White bars show PA01 background strains, dark grey bars denote a
DyfiR background. C) Surface attachment patterns of DyfiR exopoly-
saccharide mutants. Panels show attachment to polystyrene of GFP-
labeled bacteria (green) following three hours growth at 37uC. J774
macrophages are stained with DAPI (blue) and Lysotracker (red).
doi:10.1371/journal.ppat.1000804.g006
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results demonstrate that the DyfiR SCV phenotype confers
exopolysaccharide-dependent resistance to ingestion by C. elegans.
To investigate the interaction of DyfiR mutant cells with
professional phagocytic cells of the immune system, J774
macrophages were incubated with GFP-labeled PA01 variants.
When incubated for three hours with PA01 wild type, 71.964.8%
of the macrophages had taken up at least one bacterium. In
contrast, only 5.662.3% of the macrophages had phagocytosed
DyfiR mutant cells, indicating that the DyfiR SCV phenotype
confers substantial resistance to macrophage phagocytosis
(Figure 6B). To investigate the contribution of the Pel and Psl
systems to interference with internalization, the assay was repeated
with DyfiR pelG::Tn and DyfiR DpslAB mutant strains. The
percentage of macrophages that had taken up at least one
bacterium rose to 42.866.0% for the DyfiR pelG::Tn, 27.064.5%
for the DyfiR DpslAB, and to 75.665.3% for the DyfiR DpslAB
pelG::Tn triple mutant (Figure 6B). The observation that
phagocytosis of the DyfiR SCV mutant was fully restored upon
disruption of the pel and psl loci not only provided further evidence
that these exopolysaccharides represent one of the main cellular
outputs for the YfiBNR system, but in agreement with previous
studies [78,79] also confirms the notion that matrix engulfment
enables bacterial cells to escape the host immune response.
In addition to interfering with internalization, the different yfi,
psl, and pel mutants displayed markedly different surface
attachment phenotypes in this assay. Clusters of extracellular
DyfiR (pel+ psl+) mutant cells observed in the macrophage
phagocytosis assay showed a specific ‘spider-like’ organization,
where cells spread out from the central region of aggregation along
a number of defined trajectories (Figure 6C). The pattern for the
DyfiR DpslAB mutant was markedly different in that cells randomly
spread out from the central region in every direction, lacking the
radial tracks seen for DyfiR spreading. In contrast, the DyfiR
pelG::Tn mutant, although unable to form large clusters of
aggregated cells, appeared to be organized into similar linear
trajectories as the DyfiR SCV mutant (Figure 6C). No particular
cell arrangement was observed for the DyfiR DpslAB pelG::Tn triple
mutant, although few non-phagocytosed cells were seen for this
strain (Figure 6B). These observations suggest that Pel and Psl not
only contribute to cell adherence, biofilm formation, and
protection against phagocytosis, but also mediate a specific
architecture of surface attached microcolonies.
Given the clear differences in physical interaction between
macrophages and SCVs, we sought to test whether these
differences were mirrored in the internal response of the immune
cells. To test whether the DyfiR SCV phenotype affected
macrophage activation or cytotoxicity, nuclear NF-kB transloca-
tion (Figure S5) and LDH (lactate dehydrogenase) release (Figure
S6) was determined in J774 macrophages infected with PA01 wild
type and mutant cells, respectively. No significant difference in
macrophage activation was seen between samples infected with
PA01 or the DyfiR mutant. When siderophore production was
measured for the DyfiR strain, increased levels of pyoverdin and
pyochelin were found compared with wild type PA01 (Figure S7).
An increase in the production of siderophores and other excreted
‘scavenger’ molecules would appear to be consistent with the
persistence phenotype proposed for SCV strains. The DyfiR strain
also showed increased production of the phenazine pyocyanin
(Figure S7).
The DyfiR SCV phenotype persists in a murine
subcutaneous catheter infection
Although the auto-aggregative and slow growing SCV morpho-
types are at a considerable disadvantage under conditions that
permit rapid growth, they are able to persist in vivo [7]. This
phenomenon might be explained by conditions in the host
environment (e.g. immune system attack or antimicrobial chemo-
therapy) that put an even higher burden on rapidly growing, non-
adherent strains and thus provide selection for SCVs. To test this,
we compared the competitive behavior of PA01 wild type and DyfiR
SCV strains in vitro and in vivo. When grown in LB the DyfiR SCV
strain was significantly outperformed by the wild type. Also,
suppressors with wild type colony morphology quickly arose in
every DyfiR sample, forming the majority of the cell population after
18 hours incubation (Figure 7A). The addition of increasing
concentrations of tobramycin in the sub-inhibitory range led to a
reduction of both wild type and DyfiR cell numbers. However, wild
type growth decreased at a much steeper rate and at 1.5 mg/ml
tobramycin, no significant difference in cfu numbers was observed
between the two strains (Figure 7A). Likewise, in the presence of
tobramycin the number of suppressors arising from DyfiR dropped
sharply with no suppressors arising at concentrations above 0.5 mg/
ml of the inhibitor. Thus, the fitness disadvantage of the DyfiR SCV
is strongly reduced in the presence of sub-inhibitory concentrations
of tobramycin. Two observations indicate that this effect is not
linked to some form of antibiotic tolerance of the DyfiR SCV, but
rather reflects converging fitness during slow growth under stressful
conditions. Firstly, a similar relative increase of DyfiR fitness
compared to wild type was observed when cells were grown at
reduced temperatures (data not shown). Secondly, no differences in
MIC were seen between PA01 and DyfiR for tobramycin or for any
of the other antibiotics tested (Figure S8).
Next, we analyzed the DyfiR mutant in a mouse catheter model
with respect to its in vivo persistence behavior. Total bacterial
numbers and colony morphologies were scored in the catheters
and in the surrounding tissue four and eight weeks after infection
with PA01 wild type, DyfiR and DyfiBNR mutants, either
individually or in competition. When strains were infected
individually, total numbers of DyfiR mutants scored within the
catheter were significantly lower after four weeks as compared to
wild type (Figure 7B). In contrast, no significant difference was
observed between the corresponding tissue samples (Figure 7B).
Likewise, in four week competition experiments, the DyfiR mutant
was strongly outperformed by wild type in the catheter but less so
in the surrounding tissue (Figure 7C). After eight weeks of
infection, viable counts of wild type cells were significantly reduced
in the catheter compared with four-week infections. However, no
significant drop in cfu/ml was noted for the DyfiR mutant between
four and eight weeks, accounting for an improved relative
performance of the SCV mutant (Figure 7B). In competition
assays after eight weeks the wild type/DyfiR ratio decreased
relative to the four-week results in both catheter and tissue
samples. While a small (non-significant) disadvantage was still seen
for the DyfiR mutant in the catheter, no such disadvantage was
noted for the eight-week tissue samples (Figure 7C). The improved
relative performance of the DyfiR mutant appeared to be due to a
reduction in the number of wild type cfus, rather than an increase
in SCVs. Importantly, in vivo no suppressors of the SCV
morphology arose for any of the DyfiR mutant samples over the
entire course of the experiment, in contrast to the rapid emergence
of suppressors in vitro (Figure 7A). No significant differences were
seen between wild type and the DyfiBNR strain after four weeks,
either in single infections or competition experiments (data not
shown).
Together this demonstrates that the slow-growing DyfiR SCV
mutant, although suffering from a tremendous growth disadvan-
tage, shows characteristic persistence behavior under antibiotic
selection and during prolonged infection in vivo.
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Discussion
In this work we identify and characterize YfiBNR, an important
regulatory system involved in Pseudomonas aeruginosa biofilm
formation and in vivo persistence. Our research suggests that YfiB
and YfiR are upstream regulatory components of the YfiN
diguanylate cyclase, which represents the cellular readout of the
system. Activation of YfiN results in c-di-GMP production, and
the activation of several downstream targets affecting cell motility
and exopolysaccharide production. We identify YfiR as a key
player in containing YfiN activity. Mutants lacking YfiR strongly
activate YfiN leading to a characteristic SCV phenotype
distinguished by slow growth, reduced motility, a highly
aggregative and wrinkled colony morphology, strong attachment
to surfaces, and persistence in vivo. Epistatic and biochemical
analyses led to a model for YfiBNR function and control
(Figure 4E), wherein YfiR acts as small periplasmic protein that
is able to tightly repress the activity of the membrane-localized
DGC YfiN. YfiB counteracts YfiR-mediated repression of YfiN
and hence leads to increased c-di-GMP production. YfiB is a
homolog of the Pal family of lipoproteins that are anchored either
in the inner or outer membrane and directly interact with the
peptidoglycan structure via a conserved peptidoglycan-binding site
[69]. Because mutations of the tol-pal genes induce hypersensitivity
to external stress-factors [80], it is possible that YfiB plays a role in
sensing envelope stress, and, in response, stimulates an SCV
response by relaying changes in the outer cell layer to YfiN via
YfiR. The observation that DGCs like YfiN are active as dimers
[74,75], together with the possible YfiB-dependent dimerisation of
YfiR is consistent with the idea that YfiR represses YfiN activity by
interfering with its oligomerisation state. In this model, YfiB
activates YfiN by promoting the oligomerisation of YfiR, freeing
YfiN to form active dimers and thus produce c-di-GMP. An
interesting alternative regulatory mechanism for YfiN has recently
been proposed [81]. In this scheme, YfiN activity is controlled by
de-phosphorylation of the periplasmic domain by the tyrosine
phosphatase TpbA. This mechanism could in principle work in
parallel with YfiR/YfiB-mediated control of YfiN activity, or as
part of the same regulatory pathway. Further experiments are
required to fully address the modes of action of YfiB and YfiR, and
the regulatory hierarchy of the Yfi system.
While the signals that activate the Yfi system remain to be
identified, several of the downstream targets are well known.
Genetic experiments indicated that YfiN-mediated induction of
the Pel and Psl exopolysaccharides plays a central role in the SCV
morphotype. Disruption of either exopolysaccharide operon led to
a partial phenotype, while disruption of both systems produced
colonies with wild type morphology. Transcription of pel was
massively increased in the DyfiR strain compared to wild type;
much of the increase in Pel exopolysaccharide production in DyfiR
may be as a consequence of this increased transcription. Despite
the substantial contribution of Psl to the DyfiR phenotype, psl
transcription was only modestly increased in this mutant,
suggesting that c-di-GMP mediated Psl stimulation in DyfiR may
be at a different regulatory level. In an yfiBNR deletion strain, pel
transcription and surface attachment drop by approximately 40%
when compared to wild type, arguing that the Yfi system
contributes significantly to Pel and Psl-dependent biofilm forma-
tion under standard laboratory conditions. In contrast to pel and
psl transcription, cupA transcription was strongly repressed in the
DyfiR mutant under the conditions tested. Similar reciprocal
relationships between exopolysaccharide and fimbrial gene
transcription have been noted previously in P. aeruginosa [82] and
E. coli [83]. The physiological relevance of this is unknown,
Figure 7. YfiN-mediated SCVs contribute to persistence in
vitro and in vivo. A) Tobramycin survival assay with PA01 wild type
(open triangles) and DyfiR mutant (open circles). DyfiR suppressor
colonies are shown as red circles. Statistically significant differences
between PA01and DyfiR are marked with asterisks (** = p,0.01,
* = p,0.05). B) Single infections with PA01 wild type (black symbols)
and DyfiR mutant (open symbols). Catheter samples (circles) are
presented as cfu/ml, tissue samples (squares) as cfu/mg tissue.
Statistically significant differences are marked with an asterisk
(* = p,0.05). C) Competition experiments with PA01 wild type and
DyfiR mutant. The graph shows the ratio of wild type to DyfiR mutant
colonies recovered from catheters (C, circles) and tissue (T, squares)
after four and eight weeks, respectively. Values above 1 indicate
greater numbers of wild type colonies, values below 1 greater
numbers of SCVs.
doi:10.1371/journal.ppat.1000804.g007
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although one may speculate that cupA repression is a compensatory
response to the enhanced production of Pel and Psl in the SCV
state. The patterns of biofilm formation and surface attachment
observed suggested critical roles for Pel and Psl in the formation
and organization of SCV colonies, respectively. The DyfiR (pel+
psl+) mutant strain formed clusters of aggregated cells, from which
cells radiated along defined trajectories. Whereas disruption of the
pel operon appeared to primarily affect cell-cell association, a psl
mutation did not affect the number or size of cell clusters, but
rather their organization, with cells spreading out from the central
region in an apparently random fashion. While Pel appears to
provide the principal structural element of the P. aeruginosa SCV
biofilm, Psl may function more as a scaffold to mediate a specific
biofilm architecture and to ensure organized and effective biofilm
construction, in agreement with previous studies [84].
The control of Pel exopolysaccharide biosynthesis appears to
be complex, as several c-di-GMP signaling components have
been implicated with this process [12,13,25,32,36,37,40,42,45].
Recently, Starkey and co-workers [13] described two classes of
lab-derived SCVs, which in many respects resemble the
phenotype of the DyfiR mutant. While the molecular nature of
class B SCVs is unclear, members of class A could be
complemented by wspF, arguing that they were caused by
mutations that activate the WspR DGC pathway [12]. Both
classes of SCVs over-produce exopolysaccharides and display a
transcriptional profile for pel and psl similar to that observed here
for the DyfiR SCV. Likewise, CupA fimbrial adhesins do not play
a role in the SCV phenotype of either sub-class [13]. Loss of
function mutations in yfiR are thus prime candidates for class B
SCVs. Clinical and lab-derived SCVs are physiologically similar,
with a number of characteristic phenotypes in common [4,13].
Because of the relatively high frequency of loss of function
mutations, both wspF and yfiR might be important targets for
genetic adaptations leading to clinical SCV development. In
support of this, wspF mutations have already been identified in
long-term P. aeruginosa CF isolates [2]. Similarly, the SCV
phenotype of strain ClinSCV-110 appears to derive from an yfi
mutation. In addition to ClinSCV-110, another potential
candidate for a clinical yfiR SCV has also been isolated, although
the genetic basis for this SCV has not yet been identified [11].
The clinical isolate SCV-20265 reverted to a wild type
phenotype upon mutation of yfiN, strongly implicating the Yfi
system in the generation of the SCV phenotype. Surprisingly,
CupA adhesin is an important component of the SCV phenotype
of SCV-20265, contrary to our findings for the DyfiR mutant
[11]. A possible explanation for this is that the downstream
targets of YfiN in SCV-20265 may differ from those seen in the
laboratory strain.
The SCV phenotype caused by de-repression of the YfiN DGC
conferred a marked resistance to nematode scavenging and
phagocytosis by macrophages. This phenotype was shown to be
strongly dependent on exopolysaccharide production, with
concomitant disruption of the pel and psl operons restoring the
ability of nematodes to scavenge, and macrophage phagocytosis
levels to those of wild type PA01. There is evidence to suggest that
this resistance to phagocytosis derives from the protection offered
to each individual cell by the exopolysaccharide, rather than being
a consequence of cell aggregation. First, macrophages are able to
take up particles larger than many of the SCV cell aggregates [85].
Second, in contrast to wild type cells, many single cells of the SCV
strain remained un-internalized even after several hours of co-
incubation with macrophages (Figure 6C). This phenotype is in
agreement with the role of mannose receptors as major phagocytic
receptors for P. aeruginosa [86]. Exopolysaccharides may sterically
hinder binding or alter macrophage surfaces and internalization
via mannose receptors. Enhanced resistance to the immune system
may help to explain the persistence of SCV infections in the
subcutaneous catheter infection model. Although bacterial counts
of the SCV strain were initially lower due to the severe growth
impediment of this strain, SCV cell numbers remained constant
over eight weeks in both catheter and neighboring tissue samples.
In contrast, numbers of wild type cells rapidly declined during the
same time window. The exact molecular basis for SCV persistence
in vivo is currently unclear. However, given the resistance to
macrophage phagocytosis seen in vitro, and in the absence of
complicating external factors such as antibiotic stress, it is tempting
to speculate that the competitive advantage of SCVs compared
with wild type P. aeruginosa cells in long term infections is due to
immune evasion. The better relative performance of the YfiN-
mediated SCV strain in tissue compared with catheters would
suggest that exopolysaccharide protection against phagocytosis
plays a more important role in the surrounding tissue, consistent
with an increased exposure to the vascularized immune system.
Cells in a bacterial biofilm have been shown to be highly tolerant
of antibiotic treatment [87], with tolerance attributed to
characteristics including biofilm structure [88], persister cells
[89] and slow growth rates [90]. Resistance to phagocytosis and
clearance, especially following aggressive antibiotic therapy when
the bacterial load of an infection is lower, and the relative risk of
exposure to immune cells is correspondingly higher, might thus
contribute to the SCV persistence phenotype in CF patients.
Although the persistence effect of the DyfiR SCV strain observed
in these experiments was significant, even after eight weeks of
infection wild type counts were still comparable with those of the
mutant. Likewise, no SCVs arose in the animals from wild type
samples, contrary to the situation in CF patients [5,6]. Longer
periods of infection, higher infection load, and external challenges
(e.g. antibiotic stress) may increase the competitive advantage of
SCVs, resulting in a higher proportion of SCVs and the evolution
of new SCV morphotypes from the wild type population. In
support of this hypothesis, exposure to sub-lethal concentrations of
tobramycin was shown to significantly reduce the number of
suppressors arising in an in vitro culture of the DyfiR SCV strain,
and at higher concentrations, decreased the relative fitness
advantage of wild type PA01 over SCV. In addition, it is possible
that the comparatively large number of persister cells found in
biofilms could further increase the advantage of SCV-generating
mutations in the presence of antibiotic stress [89]. Work is ongoing
to investigate these possibilities.
In this study, we have identified and characterized a novel c-di-
GMP regulatory system, and investigated its role both in wild type
P. aeruginosa and in the SCV morphotype. While homologous
systems have been mentioned previously in the literature [91,92],
this work represents the first comprehensive experimental analysis
of the YfiBNR system. The YfiN cyclase is tightly controlled by its
upstream regulatory system, while loss of this control leads to the
formation of a strong SCV phenotype. In the SCV form, P.
aeruginosa adopts a hyper-adherent, aggregative lifestyle, with
significant implications for immune evasion and ultimately for
long term persistence of infection. Further research should
determine the extent to which these findings are relevant to
chronic colonization in patients with CF and implant-borne
infections.
Supporting Information
Table S1 Strains and plasmids used in this study
Found at: doi:10.1371/journal.ppat.1000804.s001 (0.11 MB PDF)
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Table S2 Primers used in this study
Found at: doi:10.1371/journal.ppat.1000804.s002 (0.02 MB PDF)
Table S3 Bacterial-two-hybrid results
Found at: doi:10.1371/journal.ppat.1000804.s003 (0.02 MB PDF)
Figure S1 Motility of the DyfiR and exopolysaccharide mutant
strains. A) Swimming, swarming and twitching motility of Pel and
Psl exopolysaccharide mutants in a wild type PA01 background. B)
Motility in the DyfiR mutant background. Motility is abolished in
the DyfiR mutation (5), but swimming and twitching are partially
restored by disruption of Pel and Psl production (6-8). C) PA01
motility (1, 9) is unaffected by expression of yfiR in trans (10). D)
The motility defect of the DyfiR mutant (5, 11) is restored by
expression of yfiR in cis (13) or in trans (12).
Found at: doi:10.1371/journal.ppat.1000804.s004 (0.10 MB PDF)
Figure S2 YfiR localizes to the periplasm. A) Alkaline
phosphatase activity in whole-cell, spheroplast and periplasmic
fractions is shown for PA01 strains expressing yfiR-phoA fusions.
Activity is seen in all fractions with full-length YfiR-PhoA, but not
with a truncated YfiR allele missing the first 33 residues including
the signal sequence. An empty vector is used for the control.
Values are expressed as A405/OD600/min 6 standard error. B)
Colony morphology of DyfiR mutants expressing yfiR-phoA fusions.
Full-length YfiR-PhoA successfully complements the SCV pheno-
type of the DyfiR strain, while truncated YfiR-PhoA does not. C)
YfiR-MCherry localizes to the periplasm, as determined by
fluorescence microscopy.
Found at: doi:10.1371/journal.ppat.1000804.s005 (0.04 MB PDF)
Figure S3 Scanning electron micrographs of PA01 and DyfiR
exopolysaccharide mutants. The scale bars in each panel represent
2 mm.
Found at: doi:10.1371/journal.ppat.1000804.s006 (0.12 MB PDF)
Figure S4 A clinically derived SCV responds to yfiR expression.
Expression of yfiR-M2 from pMR20 reverts the autoaggregative,
Congo Red binding phenotypes of ClinSCV-110. PA01 and DyfiR
strains are shown for comparison.
Found at: doi:10.1371/journal.ppat.1000804.s007 (0.03 MB PDF)
Figure S5 NF-kB activation by macrophages incubated with
DyfiR and wild type PA01. NF-kB activation level in J774
macrophages was unchanged between the DyfiR mutant and wild
type PA01. The control lane shows activation levels for
macrophages incubated without bacteria. Values are expressed
as the percentage of cells showing NF-kB translocation to the
nucleus 6 standard error.
Found at: doi:10.1371/journal.ppat.1000804.s008 (0.01 MB PDF)
Figure S6 Cytotoxicity of the DyfiR mutant strain. No significant
differences in LDH release from J774 macrophages were seen
between the DyfiR SCV mutant and wild type PA01 under the
conditions tested. Values are expressed as a percentage of the
LDH released from a fully-lysed positive control sample. The
graph shows the combined results of three independent experi-
ments 6 standard deviation.
Found at: doi:10.1371/journal.ppat.1000804.s009 (0.01 MB PDF)
Figure S7 Pyocyanin and siderophore production by the DyfiR
strain. Values are shown relative to PA01 wild type, 6 standard
error.
Found at: doi:10.1371/journal.ppat.1000804.s010 (0.01 MB PDF)
Figure S8 Antibiotic susceptibility of the DyfiR mutant strain.
Inhibition zones for different antibiotic discs are shown for PA01
and the DyfiR mutant strains. Values shown are for the diameter of
the inhibition zone in mm, and show the mean of three samples 6
standard error in each case.
Found at: doi:10.1371/journal.ppat.1000804.s011 (0.02 MB PDF)
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